# S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone

> **NCT00933127** · — · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 142 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **GENETIC:** DNA analysis
- **GENETIC:** polymerase chain reaction
- **GENETIC:** polymorphism analysis
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00933127
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2014-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00933127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00933127, "S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00933127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*